SCHEMBL17664154

SCHEMBL17664154

Cc1cc(C(N)=O)cc(C)c1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.44
UPP1 Q16831 1/20 0.43
KDM4E B2RXH2 8/20 0.41
PARP1 P09874 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
ALDH1A1 P00352 2/20 0.39
RECQL P46063 1/20 0.39
LMNA P02545 2/20 0.39
HSD17B10 Q99714 2/20 0.39
PARP15 Q460N3 1/20 0.38
PARP10 Q53GL7 1/20 0.38
PARP2 Q9UGN5 1/20 0.38
S1PR2 O95136 1/20 0.37
S1PR3 Q99500 1/20 0.37
NSD2 O96028 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
HAVCR2 Q8TDQ0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL474019 0.81 TPMT (0.48) TSHRUPP1KDM4ETDP1ALDH1A1
SCHEMBL17664048 0.75 TRPV4 (0.48) PARP1PARP15PARP10PARP2S1PR2
SCHEMBL18471225 0.75 SMN1; SMN2 (0.49) TSHRPARP1TDP1ALDH1A1RECQL
SCHEMBL10831613 0.75 PARP1 (0.46) TSHRPARP1TDP1RECQLHSD17B10
SCHEMBL2767509 0.75 S1PR3 (0.50) PARP1PARP15PARP10PARP2S1PR2
SCHEMBL26089966 0.75 MEN1 (0.42) TSHRUPP1KDM4ETDP1ALDH1A1
SCHEMBL6137034 0.73 CA12 (0.55) KDM4EALDH1A1LMNAHSD17B10MAPT
SCHEMBL1004660 0.73 PARP1 (0.50) TSHRKDM4EPARP1TDP1ALDH1A1
SCHEMBL3220166 0.73 CA1 (0.48) TSHRKDM4EPARP1ALDH1A1LMNA
SCHEMBL1397262 0.73 POLB (0.50) TSHRPARP1TDP1RECQLLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016053855-A1 SPHINGOSINE-1-PHOSPATE RECEPTOR MODULATORS FOR TREATMENT OF CARDIOPULMONARY DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2016-04-07 WO disclosed